The University of Chicago Header Logo

Connection

Marcelo A. Nobrega to Enhancer Elements, Genetic

This is a "connection" page, showing publications Marcelo A. Nobrega has written about Enhancer Elements, Genetic.
  1. Editorial. Semin Cell Dev Biol. 2016 09; 57:1.
    View in: PubMed
    Score: 0.467
  2. Beyond the ENCODE project: using genomics and epigenomics strategies to study enhancer evolution. Philos Trans R Soc Lond B Biol Sci. 2013 Dec 19; 368(1632):20130022.
    View in: PubMed
    Score: 0.385
  3. In vitro scan for enhancers at the TCF7L2 locus. Diabetologia. 2013 Jan; 56(1):121-5.
    View in: PubMed
    Score: 0.356
  4. An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers. PLoS One. 2012; 7(5):e36501.
    View in: PubMed
    Score: 0.347
  5. Transcriptional enhancers in development and disease. Genome Biol. 2012 Jan 23; 13(1):238.
    View in: PubMed
    Score: 0.340
  6. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. 2010 Sep; 20(9):1191-7.
    View in: PubMed
    Score: 0.305
  7. Scanning human gene deserts for long-range enhancers. Science. 2003 Oct 17; 302(5644):413.
    View in: PubMed
    Score: 0.191
  8. Extensive pleiotropism and allelic heterogeneity mediate metabolic effects of IRX3 and IRX5. Science. 2021 06 04; 372(6546):1085-1091.
    View in: PubMed
    Score: 0.162
  9. Altered Enhancer and Promoter Usage Leads to Differential Gene Expression in the Normal and Failed Human Heart. Circ Heart Fail. 2020 10; 13(10):e006926.
    View in: PubMed
    Score: 0.155
  10. A novel mechanism of inherited TBG deficiency: mutation in a liver-specific enhancer. J Clin Endocrinol Metab. 2015 Jan; 100(1):E173-81.
    View in: PubMed
    Score: 0.104
  11. Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia. 2014 Jan; 28(1):138-46.
    View in: PubMed
    Score: 0.095
  12. Enhancers: five essential questions. Nat Rev Genet. 2013 04; 14(4):288-95.
    View in: PubMed
    Score: 0.092
  13. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet. 2012 Jul 15; 21(14):3255-63.
    View in: PubMed
    Score: 0.086
  14. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res. 2011 Sep; 21(9):1417-25.
    View in: PubMed
    Score: 0.081
  15. Genome-wide identification of conserved regulatory function in diverged sequences. Genome Res. 2011 Jul; 21(7):1139-49.
    View in: PubMed
    Score: 0.081
  16. Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res. 2010 May; 20(5):565-77.
    View in: PubMed
    Score: 0.075
  17. Predicting tissue-specific enhancers in the human genome. Genome Res. 2007 Feb; 17(2):201-11.
    View in: PubMed
    Score: 0.060
  18. In vivo enhancer analysis of human conserved non-coding sequences. Nature. 2006 Nov 23; 444(7118):499-502.
    View in: PubMed
    Score: 0.059
  19. In vivo characterization of a vertebrate ultraconserved enhancer. Genomics. 2005 Jun; 85(6):774-81.
    View in: PubMed
    Score: 0.053
  20. Evolutionary comparison reveals that diverging CTCF sites are signatures of ancestral topological associating domains borders. Proc Natl Acad Sci U S A. 2015 Jun 16; 112(24):7542-7.
    View in: PubMed
    Score: 0.027
  21. A common genetic variant within SCN10A modulates cardiac SCN5A expression. J Clin Invest. 2014 Apr; 124(4):1844-52.
    View in: PubMed
    Score: 0.025
  22. TBX5 drives Scn5a expression to regulate cardiac conduction system function. J Clin Invest. 2012 Jul; 122(7):2509-18.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.